Total Payments
$10,454
2024 Payments
$1,972
Companies
28
Transactions
552
Medicare Patients
682
Medicare Billing
$30,349
Payment Breakdown by Category
Food & Beverage$10,449 (100.0%)
Education$5.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,449 | 551 | 100.0% |
| Education | $5.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,375 | 135 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,875 | 52 | $0 (2024) |
| Lilly USA, LLC | $845.63 | 64 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $677.90 | 18 | $0 (2021) |
| Amgen Inc. | $503.77 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $493.91 | 32 | $0 (2024) |
| Novo Nordisk Inc | $445.05 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $416.79 | 34 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $414.05 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $410.52 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,972 | 97 | AstraZeneca Pharmaceuticals LP ($613.62) |
| 2023 | $2,604 | 135 | ABBVIE INC. ($980.47) |
| 2022 | $3,045 | 167 | ABBVIE INC. ($546.59) |
| 2021 | $2,833 | 153 | Biohaven Pharmaceuticals, Inc. ($677.90) |
All Payment Transactions
552 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $52.39 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 145 | 163 | $15,380 | $7,344 |
| 2022 | 6 | 202 | 228 | $20,335 | $10,108 |
| 2021 | 6 | 167 | 177 | $15,320 | $8,701 |
| 2020 | 5 | 168 | 183 | $10,305 | $4,196 |
Total Patients
682
Total Services
751
Medicare Billing
$30,349
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 51 | $4,845 | $2,669 | 55.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 48 | 55 | $5,225 | $2,169 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 22 | $2,860 | $1,591 | 55.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 18 | 19 | $1,330 | $473.51 | 35.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $1,120 | $441.15 | 39.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 72 | 82 | $7,790 | $3,750 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 53 | $5,035 | $2,649 | 52.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 41 | 42 | $2,940 | $1,245 | 42.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 17 | 20 | $1,500 | $1,017 | 67.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $1,950 | $1,016 | 52.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 16 | $1,120 | $430.95 | 38.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 46 | 51 | $4,825 | $2,917 | 60.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 34 | $3,210 | $1,875 | 58.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 32 | 32 | $2,400 | $1,642 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 12 | $1,560 | $1,032 | 66.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 23 | 24 | $1,650 | $665.46 | 40.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 23 | 24 | $1,675 | $569.27 | 34.0% |
| 87635 | Sars-cov-2 covid-19 amp prb | Office | 2020 | 27 | 28 | $2,100 | $1,437 | 68.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 48 | 53 | $3,445 | $1,271 | 36.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 28 | $2,380 | $1,115 | 46.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 35 | 39 | $1,855 | $267.70 | 14.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 35 | 35 | $525.00 | $105.00 | 20.0% |
About Kristin Bykowski, CNP
Kristin Bykowski, CNP is a Adult Health healthcare provider based in Brookfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1932502705.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kristin Bykowski, CNP has received a total of $10,454 in payments from pharmaceutical and medical device companies, with $1,972 received in 2024. These payments were reported across 552 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($10,449).
As a Medicare-enrolled provider, Bykowski has provided services to 682 Medicare beneficiaries, totaling 751 services with total Medicare billing of $30,349. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Brookfield, OH
- Active Since 10/07/2014
- Last Updated 11/03/2025
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1932502705
Products in Payments
- VRAYLAR (Drug) $1,299
- NURTEC ODT (Drug) $1,147
- BREZTRI (Drug) $947.19
- UBRELVY (Drug) $510.22
- Kerendia (Drug) $493.91
- FARXIGA (Drug) $470.02
- QULIPTA (Drug) $466.74
- AIRSUPRA (Drug) $458.13
- KRYSTEXXA (Biological) $450.56
- MOUNJARO (Drug) $428.78
- TRELEGY ELLIPTA (Drug) $376.71
- Vascepa (Drug) $340.42
- Ozempic (Drug) $279.34
- VERQUVO (Drug) $273.46
- Aimovig (Biological) $233.99
- XARELTO (Drug) $229.07
- TRULICITY (Drug) $178.59
- EMGALITY (Drug) $175.88
- LEQVIO (Drug) $167.06
- JARDIANCE (Drug) $155.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Brookfield
Jennifer Giardina
Adult Health — Payments: $3,219
Adult Health $3,219
Melissa Litwin, Np, NP
Adult Health — Payments: $2,935
Adult Health $2,935
Mrs. Gretchen Cunningham, Cnp, CNP
Adult Health — Payments: $63.45
Adult Health $63.45
Jacqueline Bergner, Apnp, APNP
Adult Health — Payments: $37.62
Adult Health $37.62
Tammy Albelo, Apnp, APNP
Adult Health
Adult Health
Carolyn Klotz, Apnp, APNP
Adult Health
Adult Health